InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Chakma Justin. Director active across 1 company, notably ARS Pharmaceuticals, Inc.. In total, 7 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €438k. Activity tracked since 25 November 2024. The latest transaction was filed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Chakma Justin is a declarant linked to ARS Pharmaceuticals, Inc., where he is Chief Business Officer. Across 6 total filings, the 6 sampled filings cover the period from 2022-11-10 to 2024-12-13, with 0 in purchases and 438385 in sales, and the modal transaction nature is Levée d'options.